Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma.The FDA has now approved it as an add-on treatment for adults and children aged 12 and older… Read more
Wegovy (semaglutide) is a once-weekly injection that was first approved in 2017 to help with weight loss and lower the risk of heart problems.Now, the FDA has approved it to treat a liver condition called… Read more
Papzimeos (zopapogene imadenovec-drba) is a new type of immunotherapy approved to treat adults with recurrent respiratory papillomatosis (RRP).RRP is a rare condition caused by certain types of human papillomavirus (HPV), which leads to non-cancerous growths… Read more
Dawnzera (donidalorsen) is a new medicine approved to help prevent attacks of a rare genetic swelling disorder known as hereditary angioedema (HAE) in people aged 12 or older.Affecting about 7,000 people in the U.S., HAE… Read more
Hernexeos (zongertinib) is a new pill for adults with a type of advanced lung cancer called non-small-cell lung cancer (NSCLC) that has a HER2 gene mutation that causes the cancer to grow and spread faster,… Read more
Brinsupri (brensocatib) is a new oral medicine approved to treat a long-term lung disease known as non-cystic fibrosis bronchiectasis (NCFB) in adults and children ages 12 or older.It works by blocking an enzyme called DPP1,… Read more
Alhemo (concizumab-mtci) is a medicine approved to help prevent bleeding in people aged 12 or older with hemophilia A or B who don’t have inhibitors to certain blood clotting proteins.Hemophilia is a rare condition that… Read more
Modeyso (dordaviprone) is a new oral medicine that treats a rare and aggressive brain tumor, called diffuse midline glioma (DMG), that has a tumor mutation known to promote tumor growth, called an H3 K27M mutation.This… Read more
Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you get older.It’s the first and only eye… Read more
Skytrofa (lonapegsomatropin-tcgd) is a long-acting version of human growth hormone (hGH).It is already approved for children with growth hormone deficiency (GHD) and is now approved for adults with GHD.It slowly releases somatropin, the active form… Read more